[1]
M. Y. ARAFATH AA and J. B, “Enhancement of oral bioavailability via solid lipid nanoparticles of anticancer drug dasatinib - An in vitro cytotoxicity and pharmacokinetic study”, Asian J Pharm Clin Res, vol. 12, no. 6, pp. 143–145, Jun. 2019.